Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention Deficit Disorder with Hyperactivity | 21 | 2024 | 3730 | 2.270 |
Why?
|
Child Development Disorders, Pervasive | 9 | 2014 | 599 | 1.930 |
Why?
|
Bipolar Disorder | 15 | 2022 | 5131 | 1.200 |
Why?
|
Antimanic Agents | 6 | 2022 | 524 | 0.930 |
Why?
|
Autistic Disorder | 5 | 2021 | 1240 | 0.800 |
Why?
|
Methylphenidate | 3 | 2020 | 480 | 0.710 |
Why?
|
Cerebellar Nuclei | 1 | 2019 | 54 | 0.670 |
Why?
|
Rest | 3 | 2020 | 951 | 0.640 |
Why?
|
Buspirone | 1 | 2018 | 80 | 0.610 |
Why?
|
Affective Symptoms | 2 | 2018 | 418 | 0.580 |
Why?
|
Comorbidity | 15 | 2024 | 10592 | 0.570 |
Why?
|
Cerebellum | 3 | 2020 | 1522 | 0.570 |
Why?
|
Adolescent | 43 | 2024 | 89244 | 0.540 |
Why?
|
Social Behavior Disorders | 1 | 2016 | 100 | 0.510 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2014 | 1988 | 0.500 |
Why?
|
Neural Pathways | 4 | 2020 | 3120 | 0.500 |
Why?
|
Memantine | 1 | 2016 | 111 | 0.490 |
Why?
|
Child | 39 | 2024 | 80960 | 0.490 |
Why?
|
Conduct Disorder | 3 | 2022 | 245 | 0.470 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2016 | 451 | 0.440 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4423 | 0.430 |
Why?
|
Referral and Consultation | 5 | 2018 | 3628 | 0.420 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1489 | 0.400 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2010 | 1508 | 0.400 |
Why?
|
Adolescent Psychiatry | 2 | 2024 | 165 | 0.400 |
Why?
|
Psychotropic Drugs | 1 | 2017 | 881 | 0.390 |
Why?
|
Central Nervous System Stimulants | 2 | 2019 | 1170 | 0.380 |
Why?
|
Family Health | 2 | 2013 | 1255 | 0.380 |
Why?
|
Dibenzothiazepines | 1 | 2011 | 102 | 0.380 |
Why?
|
Isoxazoles | 1 | 2013 | 233 | 0.370 |
Why?
|
Child Psychiatry | 2 | 2024 | 230 | 0.370 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2022 | 6030 | 0.340 |
Why?
|
Interview, Psychological | 2 | 2011 | 810 | 0.330 |
Why?
|
Models, Neurological | 1 | 2017 | 1782 | 0.320 |
Why?
|
Gyrus Cinguli | 2 | 2012 | 1135 | 0.320 |
Why?
|
Antipsychotic Agents | 3 | 2022 | 3081 | 0.320 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 3 | 2011 | 305 | 0.320 |
Why?
|
Carbamazepine | 1 | 2010 | 224 | 0.320 |
Why?
|
Brain Mapping | 3 | 2020 | 6739 | 0.310 |
Why?
|
Young Adult | 17 | 2022 | 60131 | 0.310 |
Why?
|
Cerebral Cortex | 3 | 2020 | 5831 | 0.310 |
Why?
|
Mental Disorders | 4 | 2017 | 6876 | 0.290 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2010 | 491 | 0.290 |
Why?
|
Glutamic Acid | 1 | 2012 | 1191 | 0.270 |
Why?
|
Case-Control Studies | 9 | 2022 | 22296 | 0.260 |
Why?
|
Benzodiazepines | 2 | 2022 | 1138 | 0.250 |
Why?
|
Male | 36 | 2022 | 365203 | 0.230 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15951 | 0.230 |
Why?
|
Anxiety | 1 | 2018 | 4672 | 0.220 |
Why?
|
Humans | 50 | 2024 | 768970 | 0.220 |
Why?
|
Delayed-Action Preparations | 3 | 2019 | 969 | 0.210 |
Why?
|
Family | 1 | 2013 | 3208 | 0.200 |
Why?
|
Psychopharmacology | 2 | 2024 | 146 | 0.190 |
Why?
|
Guanfacine | 1 | 2020 | 50 | 0.180 |
Why?
|
Female | 31 | 2022 | 397515 | 0.180 |
Why?
|
Cost of Illness | 1 | 2010 | 1960 | 0.180 |
Why?
|
Pyrimidines | 1 | 2013 | 3048 | 0.180 |
Why?
|
Brief Psychiatric Rating Scale | 2 | 2018 | 108 | 0.180 |
Why?
|
Brain | 3 | 2022 | 27453 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 36854 | 0.150 |
Why?
|
Psychopathology | 1 | 2021 | 434 | 0.150 |
Why?
|
Anxiety Disorders | 4 | 2017 | 2749 | 0.150 |
Why?
|
Treatment Outcome | 11 | 2022 | 65480 | 0.150 |
Why?
|
Wechsler Scales | 1 | 2017 | 258 | 0.140 |
Why?
|
Adult | 12 | 2022 | 223851 | 0.140 |
Why?
|
Prospective Studies | 11 | 2022 | 54962 | 0.140 |
Why?
|
Ambulatory Care | 2 | 2018 | 2784 | 0.120 |
Why?
|
Age of Onset | 2 | 2014 | 3346 | 0.120 |
Why?
|
Pilot Projects | 4 | 2022 | 8748 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1399 | 0.110 |
Why?
|
Diffusion Tensor Imaging | 1 | 2022 | 2426 | 0.100 |
Why?
|
Psychiatry | 1 | 2024 | 1716 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9080 | 0.090 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2012 | 287 | 0.090 |
Why?
|
Child, Preschool | 5 | 2022 | 42683 | 0.090 |
Why?
|
Massachusetts | 3 | 2013 | 8894 | 0.090 |
Why?
|
Obsessive Behavior | 1 | 2010 | 51 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2022 | 12467 | 0.080 |
Why?
|
Compulsive Behavior | 1 | 2010 | 117 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10765 | 0.080 |
Why?
|
Propylamines | 1 | 2009 | 161 | 0.080 |
Why?
|
Personality Assessment | 1 | 2010 | 646 | 0.080 |
Why?
|
Automobile Driving | 1 | 2013 | 442 | 0.080 |
Why?
|
Triazines | 1 | 2010 | 311 | 0.070 |
Why?
|
Social Behavior | 1 | 2014 | 1146 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39394 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 4862 | 0.070 |
Why?
|
Phobic Disorders | 1 | 2010 | 441 | 0.070 |
Why?
|
Checklist | 2 | 2013 | 841 | 0.070 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 813 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10400 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12095 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6214 | 0.070 |
Why?
|
Oxygen | 1 | 2017 | 4272 | 0.060 |
Why?
|
Panic Disorder | 1 | 2009 | 613 | 0.060 |
Why?
|
Psychotherapy | 1 | 2014 | 1654 | 0.060 |
Why?
|
Exanthema | 1 | 2010 | 503 | 0.060 |
Why?
|
Psychometrics | 2 | 2011 | 3066 | 0.060 |
Why?
|
Depression | 2 | 2017 | 8231 | 0.060 |
Why?
|
Piperazines | 2 | 2022 | 2553 | 0.060 |
Why?
|
Quinolones | 1 | 2007 | 389 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2013 | 4640 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14794 | 0.050 |
Why?
|
Tic Disorders | 1 | 2024 | 140 | 0.050 |
Why?
|
Attention | 1 | 2013 | 2423 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3782 | 0.050 |
Why?
|
Psychology | 1 | 2024 | 354 | 0.050 |
Why?
|
Inositol | 1 | 2022 | 216 | 0.050 |
Why?
|
Outpatients | 1 | 2010 | 1603 | 0.050 |
Why?
|
Educational Status | 2 | 2022 | 2515 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2022 | 262 | 0.050 |
Why?
|
Alcoholism | 1 | 2011 | 1981 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2010 | 1924 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13510 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 383 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 40261 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36556 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2018 | 81903 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4628 | 0.040 |
Why?
|
Risk Factors | 5 | 2018 | 74976 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 41808 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 13021 | 0.030 |
Why?
|
Boston | 1 | 2010 | 9377 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2011 | 20245 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14752 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2013 | 4818 | 0.030 |
Why?
|
Pediatrics | 1 | 2010 | 3628 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1542 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9094 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6236 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15879 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 7148 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2913 | 0.020 |
Why?
|
Asperger Syndrome | 1 | 2010 | 57 | 0.020 |
Why?
|
Middle Aged | 2 | 2016 | 223737 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2016 | 1008 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10633 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2009 | 417 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2009 | 186 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3597 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2010 | 1629 | 0.020 |
Why?
|
Child of Impaired Parents | 1 | 2011 | 462 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8055 | 0.020 |
Why?
|
Drug Tolerance | 1 | 2007 | 365 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18435 | 0.020 |
Why?
|
Mood Disorders | 1 | 2010 | 1129 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2784 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6291 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7861 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4265 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3492 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12562 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16731 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26395 | 0.010 |
Why?
|
United States | 1 | 2011 | 73186 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_